SCHEMBL5541266

SCHEMBL5541266

CCC(C(=O)OC)c1ccc(C(=O)OC(C)(C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
RECQL P46063 1/20 0.40
MAPT P10636 2/20 0.39
LDHA P00338 1/20 0.39
LDHB P07195 1/20 0.39
RAB9A P51151 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5547216 0.88 CA12 (0.43) L3MBTL1ESR1ESR2CA12CA1
Hydrochloric Acid SCHEMBL2684961 0.87 CA12 (0.43) L3MBTL1ESR1ESR2CA12CA1
SCHEMBL2684941 0.86 L3MBTL1 (0.41) L3MBTL1ESR1ESR2CA12CA1
SCHEMBL2686420 0.86 L3MBTL1 (0.41) L3MBTL1ESR1ESR2CA12CA1
SCHEMBL31724221 0.86 SERPINE1 (0.44) L3MBTL1ESR1ESR2CA12CA1
SCHEMBL2687219 0.84 L3MBTL1 (0.40) L3MBTL1ESR1ESR2CA12CA1
SCHEMBL1754323 0.83 ALDH1A1 (0.47) CA12CA1CA2CA9CA14
SCHEMBL1919196 0.82 ESR1 (0.56) L3MBTL1ESR1ESR2MEN1KMT2A
SCHEMBL4508177 0.81 CA12 (0.44) CA12CA1CA2CA9CA14
SCHEMBL4526058 0.80 GAA (0.44) L3MBTL1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069250-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC6 L3MBTL1 2311/4885ESR1 4144/4885ESR2 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.